A detailed history of Bogart Wealth, LLC transactions in Novavax Inc stock. As of the latest transaction made, Bogart Wealth, LLC holds 10 shares of NVAX stock, worth $91. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10 -0.0%
Holding current value
$91
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

SELL
$5.76 - $12.48 $57 - $124
-10 Reduced 50.0%
10 $0
Q4 2022

Feb 06, 2023

BUY
$8.86 - $25.04 $44 - $125
5 Added 33.33%
20 $0
Q3 2022

Nov 03, 2022

BUY
$18.2 - $76.12 $182 - $761
10 Added 200.0%
15 $0
Q2 2022

Jul 22, 2022

SELL
$36.28 - $75.29 $181 - $376
-5 Reduced 50.0%
5 $0
Q1 2022

Apr 22, 2022

SELL
$69.73 - $142.9 $1,394 - $2,858
-20 Reduced 66.67%
10 $1,000
Q3 2021

Oct 15, 2021

BUY
$177.8 - $270.58 $3,556 - $5,411
20 Added 200.0%
30 $6,000
Q4 2020

Jan 14, 2021

BUY
$78.74 - $139.5 $787 - $1,395
10 New
10 $1,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $718M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Bogart Wealth, LLC Portfolio

Follow Bogart Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.